Treated large posterior fossa vestibular schwannoma and meningioma: Hearing outcome and willingness‐to‐accept brain implant for unilateral deafness
Open Access
- 27 October 2022
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 2057-2063
Abstract
Background/Objective: To compare functional hearing and tinnitus outcomes in treated large (~ 3 cm) vestibular schwannoma (VS) and posterior fossa meningioma cohorts, and construct willingness‐to‐accept profiles for an experimental brain implant to treat unilateral hearing loss.Methods: A two‐way MANOVA model with two independent variables (tumor type; time from treatment) and three dependent variables (hearing effort of tumor ear; abbreviated Speech, Spatial, and Qualities of Hearing scale (SSQ12); Tinnitus Functional Index (TFI)) was used to analyze data from VS (N = 32) and meningioma (N = 50) patients who were treated at a tertiary care center between 2010 and 2020. A query to probe acceptance of experimental treatment for hearing loss relative to expected benefit was used to construct willingness‐to‐accept profiles.Results: Tumor type was statistically significant on the combined dependent variables analysis (F[3, 76] = 19.172, p < .0005, Wilks' Λ = 0.569). Meningioma showed better outcome for hearing effort (F[1, 76] = 14.632, p < .0005) and SSQ12 (F[1, 76] = 16.164, p < .0005), but not for TFI (F[1, 76] = 1.247, p = .268) on univariate two‐way ANOVA analyses. Superior hearing effort and SSQ12 indices in the short‐term (< 2 years) persisted in the long‐term (> 2 years) (p ≤ .017). At the 60% speech understanding level, 77% of respondents would accept an experimental brain implant.Conclusion: Hearing outcome is better for posterior fossa meningioma compared to VS. Most patients with hearing loss in the tumor ear would consider a brain implant if the benefit level would be comparable to a cochlear implant.Level of Evidence: 2Keywords
This publication has 54 references indexed in Scilit:
- A short form of the Speech, Spatial and Qualities of Hearing scale suitable for clinical use: The SSQ12International Journal of Audiology, 2013
- Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implantsJournal of Neurosurgery, 2011
- Temporal bone histopathology in neurofibromatosis type 2The Laryngoscope, 2011
- Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypesOncogene, 2011
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Cochlear Implantation in Neurofibromatosis Type 2 After Radiation TherapyOtology & Neurotology, 2010
- Outcomes in Nontumor Adults Fitted With the Auditory Brainstem ImplantOtology & Neurotology, 2009
- Auditory Midbrain ImplantOtology & Neurotology, 2007
- HEARING PRESERVATION IN CEREBELLOPONTINE ANGLE TUMOR SURGERY: THE NYU EXPERIENCE 1974-1991Otology & Neurotology, 1993
- Restoration of Hearing after Removal of Cerebellopontine Angle Meningioma: Diagnostic and Therapeutic ImplicationsNeurosurgery, 1988